BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32446996)

  • 21. Spectrum of cytomorphological features of extranodal NK/T-cell lymphoma, nasal type.
    Kaur K; Kakkar A; Bhardwaj N; Sakthivel P; Singh CA; Jain D; Mathur SR; Iyer VK; Sood R
    Cytopathology; 2019 Jul; 30(4):393-401. PubMed ID: 30980430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
    Celentano A; Mascolo M; Cirillo N; De Rosa G; Mignogna MD
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):381-384. PubMed ID: 28061034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T-cell lymphoma, nasal type.
    Tian S; Li R; Wang T; Wang S; Tao R; Hu X; Ding H
    Cancer Med; 2019 Jul; 8(7):3349-3358. PubMed ID: 31050212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late diagnosis: a case of rapidly progressive extranodal NK/T cell lymphoma, nasal type.
    Mori H; Ebisawa K; Nishimura M; Kanazawa K
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29455176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
    Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
    Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?
    Kim SJ; Oh SY; Hong JY; Chang MH; Lee DH; Huh J; Ko YH; Ahn YC; Kim HJ; Suh C; Kim K; Kim WS
    Ann Oncol; 2010 May; 21(5):1058-63. PubMed ID: 19850636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extranodal natural killer/T-cell lymphoma, nasal type developing central nervous system and epididymis involvement immediately after concurrent chemoradiotherapy].
    Sasaki Y; Yonezawa A; Kinoshita Y; Kitagawa T; Mori M; Onaka T; Imada K
    Rinsho Ketsueki; 2015 Dec; 56(12):2472-6. PubMed ID: 26725358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Extranodal Natural Killer/T-Cell Lymphoma, nasal-type with primary cutaneous involvement. A case report].
    Silva-Feistner M; Rojas-Lechuga MJ; Ortiz E; Molgó M
    Rev Chil Pediatr; 2018 Apr; 89(2):246-250. PubMed ID: 29799894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
    Chang BH; Stork L; Fan G
    Pediatr Dev Pathol; 2008; 11(1):50-4. PubMed ID: 18237230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extranodal natural killer/T-cell lymphoma, nasal type, of the orbit mimicking recurrent orbital cellulitis.
    Kim JW; An JH
    J Craniofac Surg; 2014 Mar; 25(2):509-11. PubMed ID: 24621697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extranodal natural killer/T-cell lymphoma, nasal-type.
    Chorianopoulos D; Samitas K; Vittorakis S; Kiriazi V; Rondoyianni D; Tsaousis G; Skoutelis A
    Skinmed; 2010; 8(1):56-8. PubMed ID: 20839428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
    Yamaguchi M; Suzuki R; Oguchi M
    Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extranodal NK/T cell lymphoma, nasal type, with retrobulbar extraconal phlegmon and naso-oral fistula.
    Wong DJY; Parry LA; Bloch AE; Agar N
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30852512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
    Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
    Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodal presentation of nasal-type NK/T-cell lymphoma. Report of two cases with fine needle aspiration cytology findings.
    Ng WK; Lee CY; Li AS; Cheung LK
    Acta Cytol; 2003; 47(6):1063-8. PubMed ID: 14674081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extranodal natural killer/T-cell lymphoma nasal type.
    Daines BS; Varman RM; Nguyen TQ
    Proc (Bayl Univ Med Cent); 2022; 35(5):672-674. PubMed ID: 35991731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasal-type extranodal natural killer/T-cell lymphoma presenting as a solitary non-healing lower leg ulcer.
    Liaw TY; Hu SC
    Australas J Dermatol; 2016 Feb; 57(1):e17-9. PubMed ID: 25496526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.
    Makita S; Tobinai K
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):239-253. PubMed ID: 28340876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as Refractory
    Reategui Schwarz E; Oikonomou KG; Reynolds M; Kim J; Balmiki RL; Sterling SA
    J Investig Med High Impact Case Rep; 2017; 5(3):2324709617716471. PubMed ID: 28748192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The significance of peripheral blood natural killer cell surface CD
    Liu JX; Wang JW; Cui XY
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):872-874. PubMed ID: 27801344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.